SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
272Cambridge Antibody Technology founder quits By David Firn Published: November 26Icebrg-11/27/2001
271GPC Biotech Signs Agreement with ICOS to Manufacture Antibodies for Clinical StuIcebrg-11/26/2001
270Happy Thanksgiving, all ! And thanks to Tuck - Message 16693625nigel bates-11/22/2001
269GZMO and Kirin: You can't win them all. I wonder what Medarex feels about tIcebrg-11/19/2001
268Genzyme Molecular Oncology and Kirin Form Partnership to Develop Antibody Therapnigel bates-11/19/2001
267Another week - another partnership for MEDX. <b>Medarex and Ambit BioscieIcebrg-11/19/2001
266Xoma CEO in Nov. 6 presentation said all phage companies are in violation of XOMaknahow-11/16/2001
265Yeah, from the land of the ADR's.scaram(o)uche-11/14/2001
264Nigel, thanks for the heads up on grammar. Yous Brits are painfully aware that wMark Bong-11/14/2001
263Nigel I am not so sure their intention is to start licensing this technology toIcebrg-11/14/2001
262Wonder if they will recoup the cost of acquisition by licensing to Celltech, liknigel bates-11/13/2001
261Abgenix Acquires Catalytic Antibody Technology New Class of Therapeutic AntibodiIcebrg-11/13/2001
260Anyone know anything about this ? PIERIS Releases Human Anticalin(R) Library winigel bates-11/13/2001
259I am becoming more and more impressed by Medarex ability to build product develoIcebrg-11/12/2001
258Medarex and m-phasys Announce Alliance to Develop Human Antibody Therapeutics Pnigel bates-11/12/2001
257Genmab's Humax-CD4 Shows Statistically Significant Dose Response In This prnigel bates-11/12/2001
256In context, also means this, at present XOMA has only 25+ cell expression licensaknahow-11/9/2001
255For the benefit of those posting to this thread, if in doubt about the correct unigel bates-11/9/2001
254<i>Xoma..CEO says it is talking to 14 companies that will need to license nigel bates-11/9/2001
253>> are far more powerful << That's irritating as hell coming frscaram(o)uche-11/8/2001
252Richard, You have to look at what the new toxin's are doing. Ricin was larGary Mohilner-11/8/2001
251>> While it's not a part of that article, it should be recognized thatscaram(o)uche-11/8/2001
250Xoma will be taking such a fusion protein into clinic by early nest year. Gelonaknahow-11/7/2001
249Ice, While it's not a part of that article, it should be recognized that thGary Mohilner-11/7/2001
248Medarex seem to be the more aggressive of the twins at present. At least PR-wiseIcebrg-11/7/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News